Novartis Gene Therapies was formerly AveXis, whose gene therapy technology is based on the work of Jude Samulski, PhD, Professor of ºÚÁÏÍø Pharmacology and member of the ºÚÁÏÍø Gene Therapy Center.

Dr. Samulski is renown for the development of the harmless adeno-associated virus (AAV) as a vector, or delivery tool, for genes, and was the director of the ºÚÁÏÍø Gene Therapy Center for many years.
Novartis Gene Therapies has manufacturing facilities in Durham Co., NC. and is the largest gene therapy manufacturer in the world.